Sandoz France in the news
Generic and biosimilar drugs
Tamtam found 20 recent articles about Sandoz France.
- Avec 150 millions d’euros d’investissements, Sandoz conforte l’ancienne usine Evotec de Toulouse comme son site clé pour la production de biosimilaires
Sandoz is investing 150 million euros to expand its Toulouse facility with a new production line and increased capacity for manufacturing biosimilar drugs.
- Sandoz et Stallergenes Greer augmentent leurs investissements en France
Sandoz and Stallergenes Greer are investing a combined 275 million euros to expand their pharmaceutical manufacturing sites in France.
- Biomédicaments : à Toulouse, Sandoz renforce sa capacité industrielle avec 150 M€ supplémentaires
Sandoz is investing an additional 150 million euros to increase the production capacity of biosimilar medicines at its strategic industrial site in Toulouse.
- Sandoz annonce un nouvel investissement de 150 M€ pour son usine toulousaine
Sandoz is investing 150 million euros through 2034 to modernize and expand its production facility in Toulouse.
- Haute-Garonne - Sandoz annonce un investissement supplémentaire de 150 M€ dans son site toulousain
Sandoz is investing 150 million euros in its Toulouse site to develop a strategic European hub for biosimilar drug production.
- Bioproduction : Sandoz prévoit 150 millions d’euros pour renforcer sa production de biosimilaires sur son site de Toulouse, tout juste racheté à Evotec
Sandoz invests 150 million euros to expand biosimilar production at its recently acquired Toulouse site, enhancing capacity and creating a new production line.
- Sandoz va investir 150 millions d’euros supplémentaires dans son site toulousain
Sandoz is investing 150 million euros to expand its biosimilar production facility in Toulouse to capture market growth from expiring biological drug patents.
- France: nouveaux investissements des laboratoires GSK et Sandoz
Sandoz is investing 150 million euros in its Toulouse site to expand biosimilar production and development through 2034.
- Sommet Choose France : le Suisse Sandoz annonce 150 M€ d’investissement pour son site de biomédicaments de Toulouse
Sandoz is investing 150 million euros to expand its biosimilar production facility and add a new manufacturing line in Toulouse.
- Santé : l’usine toulousaine Evotec passe sous pavillon suisse avec Sandoz et s’ouvre un potentiel à plusieurs milliards
Sandoz acquired a 350 million euro biologics plant in Toulouse to expand its production of biosimilar drugs.
- Sandoz mise toujours plus sur l’Europe et les biosimilaires
Sandoz, now independent, reported significant revenue and profit growth, driven by its focus on generic and biosimilar drugs in Europe.
- Sandoz Positions to Lead 'Golden Decade' of Affordable Medicines as $600 Billion in Drugs Lose Exclusivity
Sandoz is leveraging its standalone status and recent manufacturing expansions to capture a massive market share as USD 600 billion worth of medicines lose patent protection.
- Pourquoi le laboratoire suisse Sandoz préfère investir en Europe plutôt qu’aux États-Unis
Sandoz acquired a 250 million euro monoclonal antibody production facility in France to expand its European biosimilar manufacturing capacity.
- Evotec vient de boucler la vente définitive de son usine toulousaine au Suisse Sandoz
Sandoz has acquired a newly built monoclonal antibody production facility in Toulouse from Evotec for 350 million dollars in cash.
- UPS, Cencora to expand their US operations; Evotec divests biosimilar business to Sandoz
UPS and Cencora are expanding their US operations, while Evotec divests its biosimilar business to Sandoz.
- Sandoz to acquire Just-Evotec Biologics to strengthen biosimilar development and manufacturing capabilities
Sandoz is acquiring Just-Evotec Biologics and its Toulouse manufacturing facility for $350 million to expand its biosimilar production capacity.
- Lupin inks deal with Sandoz for Ranibizumab biosimilar
Partnership with Lupin to commercialize a ranibizumab biosimilar in Europe, Australia, and Canada while sharing rights in France.
- Sandoz inks deal to acquire Just-Evotec Biologics in Toulouse, France
Sandoz plans to acquire the Just-Evotec Biologics manufacturing facility in Toulouse for $300 million to expand its biosimilar production capacity.
- Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition
A $300 million acquisition of a French manufacturing facility will move biosimilar production in-house and expand European operations.
- Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France
Sandoz plans to acquire a biologics manufacturing facility in Toulouse for $300 million to boost its internal biosimilar production capacity.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Sandoz France?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies